DHC-Virtual
January 20 - 21, 2021
NL
EN
Dutch Hematology Congress
Welcome
CGR Code of Conduct and congress policy
Organization
Contact
congres information DHC Virtual
Information for speakers and moderators
video
Registration
DHC program & Program Nursing symposium
Accreditation
Sponsors and non-profit organizations
Privacy
Menu
Program DHC-Virtual
20 - 21 January 2021
Clinical Abstracts session 1
Abstract
Dr. H.J. Boiten
Drs. T.T. de Waal
Name
Description
Date
Times
Location
Long-term follow-up and biomarker analyses of r/r Hodgkin lymphoma treated with BV-DHAP.
20 January
08:30
08:42
Virtual
Virtual room 1
Effective treatment with Ibrutinib in cold agglutinin disease/cold agglutinin syndrome
20 January
08:42
08:54
Virtual
Virtual room 1
Predictive value of baseline radiomics features in DLBCL
20 January
08:54
09:06
Virtual
Virtual room 1
Impact of rituximab biosimilars on overall survival in DLBCL
20 January
09:06
09:18
Virtual
Virtual room 1
Questions, answers and discussion
20 January
09:18
09:30
Virtual
Virtual room 1
Dutch Hematology Congress
Welcome
CGR Code of Conduct and congress policy
Organization
Contact
congres information DHC Virtual
Information for speakers and moderators
video
Registration
DHC program & Program Nursing symposium
Accreditation
Sponsors and non-profit organizations
Privacy
×